Journal article

Gut hormones, incretin mimetics and gliptins: new understanding and novel therapies in type 2 diabetes.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Munro, N., & Levy, J. (2007). Gut hormones, incretin mimetics and gliptins: new understanding and novel therapies in type 2 diabetes. Primary Care Diabetes, 1(2), 103–105.

MLA Style

Munro, N., and J. Levy. “Gut Hormones, Incretin Mimetics and Gliptins: New Understanding and Novel Therapies in Type 2 Diabetes.” Primary Care Diabetes, vol. 1, no. 2, 2007, pp. 103–05.

Chicago Style

Munro, N, and J Levy. 2007. “Gut Hormones, Incretin Mimetics and Gliptins: New Understanding and Novel Therapies in Type 2 Diabetes.” Primary Care Diabetes 1 (2): 103–5.
Share
Print

Access Document

Publisher copy:: 10.1016/j.pcd.2007.04.003

Authors

+ Munro, N More by this author

Role:: Author

+ Levy, J More by this author

Institution:: University of Oxford
Division:: MSD
Department:: RDM
Sub department:: OCDEM
Role:: Author

Journal:: Primary care diabetes More from this journal
Volume:: 1
Issue:: 2
Pages:: 103-105
Publication date:: 2007-06-01
DOI:: 10.1016/j.pcd.2007.04.003
EISSN:: 1878-0210
ISSN:: 1751-9918

Language:: English
Keywords:: Glucagon-Like Peptide 1

Dipeptidyl-Peptidase IV Inhibitors

Diabetes Mellitus, Type 2

Insulin

Incretins

Humans

Gastric Inhibitory Polypeptide
Pubs id:: pubs:94791
UUID:: uuid:49cc6a68-400f-4146-af49-9db08ad245f5
Local pid:: pubs:94791
Source identifiers:: 94791
Deposit date:: 2012-12-19

Terms of use

Copyright date:: 2007

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP